Hidden threat: hepatitis d prevalence under the microscope
NCT ID NCT06638320
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find out how often people with chronic hepatitis B also have hepatitis D, and which types of the virus are most common. Researchers will interview about 2,400 participants and take blood samples to look for links with vaccination history, lifestyle, and other factors. No new treatment is being tested—this is purely an information-gathering study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bach Mai General Hospital
RECRUITINGHà Nội, Northern Vietnam, 100000, Vietnam
-
Tam Anh General Hospital
RECRUITINGHà Nội, Northern Vietnam, 100000, Vietnam
-
Tam Anh TP. Ho Chi Minh General Hospital
RECRUITINGHo Chi Minh City, Southern Vietnam, 700000, Vietnam
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new injection tame chronic hepatitis b?
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
- A second punch against hepatitis b: interferon after RNA drugs may clear the virus
- Could common hepatitis b drugs damage kidneys? a study digs into the data
- Can fatty liver and hepatitis b together harm kidneys? a study digs into the data